BAPULM: Binding Affinity Prediction using Language Models
- URL: http://arxiv.org/abs/2411.04150v1
- Date: Wed, 06 Nov 2024 04:35:30 GMT
- Title: BAPULM: Binding Affinity Prediction using Language Models
- Authors: Radheesh Sharma Meda, Amir Barati Farimani,
- Abstract summary: We introduce BAPULM, an innovative sequence-based framework that leverages the chemical latent representations of proteins via ProtT5-XL-U50 and through MolFormer.
Our approach was validated extensively on benchmark datasets, achieving sequential scoring power (R) values of 0.925 $pm$ 0.043, 0.914 $pm$ 0.004, and 0.8132 $pm$ 0.001 on benchmark1k2101, Test2016_290, and CSAR-HiQ_36, respectively.
- Score: 7.136205674624813
- License:
- Abstract: Identifying drug-target interactions is essential for developing effective therapeutics. Binding affinity quantifies these interactions, and traditional approaches rely on computationally intensive 3D structural data. In contrast, language models can efficiently process sequential data, offering an alternative approach to molecular representation. In the current study, we introduce BAPULM, an innovative sequence-based framework that leverages the chemical latent representations of proteins via ProtT5-XL-U50 and ligands through MolFormer, eliminating reliance on complex 3D configurations. Our approach was validated extensively on benchmark datasets, achieving scoring power (R) values of 0.925 $\pm$ 0.043, 0.914 $\pm$ 0.004, and 0.8132 $\pm$ 0.001 on benchmark1k2101, Test2016_290, and CSAR-HiQ_36, respectively. These findings indicate the robustness and accuracy of BAPULM across diverse datasets and underscore the potential of sequence-based models in-silico drug discovery, offering a scalable alternative to 3D-centric methods for screening potential ligands.
Related papers
- A Unified Approach to Inferring Chemical Compounds with the Desired Aqueous Solubility [5.763661159910719]
Aqueous solubility (AS) is a key physiochemical property that plays a crucial role in drug discovery and material design.
We report a novel unified approach to predict and infer chemical compounds with the desired AS based on simple deterministic graph-theoretic descriptors.
arXiv Detail & Related papers (2024-09-06T14:20:38Z) - YZS-model: A Predictive Model for Organic Drug Solubility Based on Graph Convolutional Networks and Transformer-Attention [9.018408514318631]
Traditional methods often miss complex molecular structures, leading to inaccuracies.
We introduce the YZS-Model, a deep learning framework integrating Graph Convolutional Networks (GCN), Transformer architectures, and Long Short-Term Memory (LSTM) networks.
YZS-Model achieved an $R2$ of 0.59 and an RMSE of 0.57, outperforming benchmark models.
arXiv Detail & Related papers (2024-06-27T12:40:29Z) - TAGMol: Target-Aware Gradient-guided Molecule Generation [19.977071499171903]
3D generative models have shown significant promise in structure-based drug design (SBDD)
We decouple the problem into molecular generation and property prediction.
The latter synergistically guides the diffusion sampling process, facilitating guided diffusion and resulting in the creation of meaningful molecules with the desired properties.
We call this guided molecular generation process as TAGMol.
arXiv Detail & Related papers (2024-06-03T14:43:54Z) - Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
Conditional generation based on the target IC50 score can obtain a more effective sampling space.
Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
arXiv Detail & Related papers (2024-05-23T13:22:17Z) - Optimizing OOD Detection in Molecular Graphs: A Novel Approach with Diffusion Models [71.39421638547164]
We propose to detect OOD molecules by adopting an auxiliary diffusion model-based framework, which compares similarities between input molecules and reconstructed graphs.
Due to the generative bias towards reconstructing ID training samples, the similarity scores of OOD molecules will be much lower to facilitate detection.
Our research pioneers an approach of Prototypical Graph Reconstruction for Molecular OOD Detection, dubbed as PGR-MOOD and hinges on three innovations.
arXiv Detail & Related papers (2024-04-24T03:25:53Z) - SE(3)-Invariant Multiparameter Persistent Homology for Chiral-Sensitive
Molecular Property Prediction [1.534667887016089]
We present a novel method for generating molecular fingerprints using multi parameter persistent homology (MPPH)
This technique holds considerable significance for drug discovery and materials science, where precise molecular property prediction is vital.
We demonstrate its superior performance over existing state-of-the-art methods in predicting molecular properties through extensive evaluations on the MoleculeNet benchmark.
arXiv Detail & Related papers (2023-12-12T09:33:54Z) - Drug Synergistic Combinations Predictions via Large-Scale Pre-Training
and Graph Structure Learning [82.93806087715507]
Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation.
Deep learning models have emerged as an efficient way to discover synergistic combinations.
Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
arXiv Detail & Related papers (2023-01-14T15:07:43Z) - From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph-Based Deep Learning [40.83037811977803]
Dynaformer is a graph-based deep learning model developed to predict protein-ligand binding affinities.
It exhibits state-of-the-art scoring and ranking power on the CASF-2016 benchmark dataset.
In a virtual screening on heat shock protein 90 (HSP90), 20 candidates are identified and their binding affinities are experimentally validated.
arXiv Detail & Related papers (2022-08-19T14:55:12Z) - SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity
Prediction [127.43571146741984]
Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery.
wet experiments remain the most reliable method, but they are time-consuming and resource-intensive.
Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue.
We present the SSM-DTA framework, which incorporates three simple yet highly effective strategies.
arXiv Detail & Related papers (2022-06-20T14:53:25Z) - Improved Drug-target Interaction Prediction with Intermolecular Graph
Transformer [98.8319016075089]
We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture.
Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively.
IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
arXiv Detail & Related papers (2021-10-14T13:28:02Z) - A Systematic Approach to Featurization for Cancer Drug Sensitivity
Predictions with Deep Learning [49.86828302591469]
We train >35,000 neural network models, sweeping over common featurization techniques.
We found the RNA-seq to be highly redundant and informative even with subsets larger than 128 features.
arXiv Detail & Related papers (2020-04-30T20:42:17Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.